Novomics Co., Ltd. (XKON: 283100)
South Korea
· Delayed Price · Currency is KRW 630.00
0.00 (0.00%)
At close: Sep 10, 2024
Novomics Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '22 Dec 31, 2022 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2017 |
| Revenue | 206.03 | 206.03 | 303.57 | 95.21 | 5.39 | - | Upgrade
|
| Revenue Growth (YoY) | - | -32.13% | 218.83% | 1665.91% | - | - | Upgrade
|
| Cost of Revenue | 160.9 | 160.9 | 201.78 | 125.28 | 23.42 | 1.75 | Upgrade
|
| Gross Profit | 45.13 | 45.13 | 101.78 | -30.07 | -18.03 | -1.75 | Upgrade
|
| Selling, General & Admin | 2,951 | 2,951 | 3,033 | 2,677 | 3,044 | 2,672 | Upgrade
|
| Research & Development | 1,747 | 1,747 | 1,510 | 2,175 | 1,063 | 860.82 | Upgrade
|
| Other Operating Expenses | 8 | 8 | 10.89 | 3.99 | 1.67 | 53.05 | Upgrade
|
| Operating Expenses | 5,350 | 5,350 | 5,182 | 5,494 | 4,713 | 3,863 | Upgrade
|
| Operating Income | -5,305 | -5,305 | -5,080 | -5,524 | -4,731 | -3,865 | Upgrade
|
| Interest Expense | -407.99 | -407.99 | -1,205 | -2,903 | -2,473 | -1,450 | Upgrade
|
| Interest & Investment Income | 53.67 | 53.67 | 72.44 | 142.24 | 216.04 | 91.9 | Upgrade
|
| Currency Exchange Gain (Loss) | -4.21 | -4.21 | 4.48 | -24.19 | 11.82 | -5.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 2,233 | 2,233 | -640.73 | -37,339 | 396.88 | -1,228 | Upgrade
|
| EBT Excluding Unusual Items | -3,430 | -3,430 | -6,849 | -45,648 | -6,579 | -6,456 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.01 | -0.08 | - | - | Upgrade
|
| Other Unusual Items | 11.87 | 11.87 | - | 26.36 | - | - | Upgrade
|
| Pretax Income | -3,418 | -3,418 | -6,849 | -45,622 | -6,579 | -6,456 | Upgrade
|
| Net Income | -3,418 | -3,418 | -6,849 | -45,622 | -6,579 | -6,456 | Upgrade
|
| Net Income to Common | -3,418 | -3,418 | -6,849 | -45,622 | -6,579 | -6,456 | Upgrade
|
| Shares Outstanding (Basic) | 7 | 7 | 6 | 3 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 7 | 7 | 6 | 3 | 3 | 3 | Upgrade
|
| Shares Change (YoY) | 142.67% | 18.35% | 84.37% | 11.21% | - | 1.80% | Upgrade
|
| EPS (Basic) | -523.33 | -523.33 | -1241.01 | -15241.15 | -2444.23 | -2398.73 | Upgrade
|
| EPS (Diluted) | -523.33 | -523.33 | -1241.01 | -15241.15 | -2444.23 | -2399.00 | Upgrade
|
| Free Cash Flow | -4,452 | -4,452 | -4,187 | -5,630 | -4,317 | -4,042 | Upgrade
|
| Free Cash Flow Per Share | -681.64 | -681.64 | -758.69 | -1880.93 | -1604.04 | -1501.60 | Upgrade
|
| Gross Margin | 21.91% | 21.91% | 33.53% | -31.58% | - | - | Upgrade
|
| Operating Margin | -2574.77% | -2574.77% | -1673.59% | -5801.81% | -87743.46% | - | Upgrade
|
| Profit Margin | -1659.01% | -1659.01% | -2256.11% | -47915.33% | -122015.20% | - | Upgrade
|
| Free Cash Flow Margin | -2160.91% | -2160.91% | -1379.27% | -5913.29% | -80072.90% | - | Upgrade
|
| EBITDA | -4,603 | -4,603 | -4,378 | -4,839 | -4,117 | -3,587 | Upgrade
|
| D&A For EBITDA | 701.74 | 701.74 | 702.78 | 684.91 | 614.23 | 277.96 | Upgrade
|
| EBIT | -5,305 | -5,305 | -5,080 | -5,524 | -4,731 | -3,865 | Upgrade
|
| Advertising Expenses | 641.75 | 641.75 | 682.1 | 555.86 | 373.84 | 355.36 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.